Sinonasal and Asthma Outcomes after Aspirin Desensitization following Endoscopic Sinus Surgery in Aspirin Exacerbated Respiratory Disease
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Aspirin exacerbated respiratory disease (AERD) is a well-known disease characterized by the triad of bronchial asthma, nasal polyps, and aspirin intolerance. AERD has been known to be the most severe form of chronic rhinosinusitis, marked by a larger polyp burden and higher rates of recurrence after endoscopic sinus surgery (ESS). Although ESS improves sinonasal symptoms and asthma severity score, it does not address the underlying abnormal metabolism of arachidonic acid. Herein, we describe two cases of AERD presented as recurrent nasal polyposis after ESS, which was successfully treated with aspirin desensitization following ESS.
Abstract
Aspirin exacerbated respiratory disease (AERD) is a well-known disease characterized by the triad of bronchial asthma, nasal polyps, and aspirin intolerance. AERD has been known to be the most severe form of chronic rhinosinusitis, marked by a larger polyp burden and higher rates of recurrence after endoscopic sinus surgery (ESS). Although ESS improves sinonasal symptoms and asthma severity score, it does not address the underlying abnormal metabolism of arachidonic acid. Herein, we describe two cases of AERD presented as recurrent nasal polyposis after ESS, which was successfully treated with aspirin desensitization following ESS.
참고문헌 (14)
- White AA, "Aspirin-exacerbated respiratory disease", N Engl J Med, 379, pp.1060~1070 (2018)
- Larivée N, "Aspirin desensitization therapy in aspirin-exacerbated respiratory disease : a systematic review", Int Forum Allergy Rhinol, 10(4), pp.450~464 (2020)
- 김성동, "Samter’s Triad: State of the Art", Clinical and Experimental Otorhinolaryngology, 11(2), pp.71~80 (2018), 대한이비인후과학회[DOI]
- Widal F, "First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome(plus urticaria)--1922(with a note on aspirin desensitization)", J Asthma : Official J Assoc Care Asthma, 24(5), pp.297~300 (1987)
- Szczeklik A, "Aspirin intolerance and the cyclooxygenase–leukotriene pathways", Curr Opin Pulm Med, 10(1), pp.51~56 (2004)
- Szczeklik A, "Clinical features and diagnosis of aspirin induced asthma", Thorax, 55(Suppl 2), pp.S42~S44 (2000)
- Bochenek G, "Testing for aspirin hypersensitivity", Allergy, 57(7), pp.562~565 (2002)
- Nizankowska E, "Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma", Eur Respir J, 15(5), pp.863~869 (2000)
- Havel M, "Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad", Eur Arch Otorhinolaryngol, 270(2), pp.571~578 (2013)
- Rachel U. Lee, "Aspirin-Exacerbated Respiratory Disease: Evaluation and Management", Allergy, Asthma & Immunology Research, 3(1), pp.3~10 (2011), 대한천식알레르기학회
- Levy JM, "Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease : an evidence-based review with recommendations", Int Forum Allergy Rhinol, 6(12), pp.1273~1283 (2016)
- Adappa ND, "Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin-exacerbated respiratory disease", Int Forum Allergy Rhinol, 8(1), pp.49~53 (2018)
- Cho KS, "Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease", Otolaryngol Head Neck Surg, 151(4), pp.575~581 (2014)
- Yong M, "Cost-effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirinexacerbated respiratory disease", Int Forum Allergy Rhinol, 11(12), pp.1626~1636 (2021)